The effect of ultrasound-guided botulinum toxin injections on pain, functionality, spasticity, and range of motion in patients with post-stroke upper extremity spasticity

被引:0
作者
Celebi, G. [1 ]
Ayyildiz, A. [2 ]
Inceoglu, S. Ciftci [3 ]
Kuran, B. [3 ]
机构
[1] Bahcesehir Univ, Goztepe Med Pk Hosp, Dept Phys Med & Rehabil, Istanbul, Turkiye
[2] Cam & Sakura City Hosp, Dept Phys Med & Rehabil, Minist Hlth, Istanbul, Turkiye
[3] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Phys Med & Rehabil, Istanbul, Turkiye
来源
REHABILITACION | 2025年 / 59卷 / 01期
关键词
Botulinum toxin; Spasticity; Stroke; Ultrasound-guided injection; UPPER-LIMB SPASTICITY; SHOULDER PAIN; DOUBLE-BLIND; STROKE; EPIDEMIOLOGY; HEMIPLEGIA; IMPROVE; ARM;
D O I
10.1016/j.rh.2024.100876
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: Spasticity developing in the upper extremity in stroke patients causes disability by limiting movement and causing pain. This study investigates the effects of botulinum toxin injections on pain, functionality, spasticity, and range of motion in hemiplegic patients with post-stroke spasticity. Materials and methods: The study involved a double-blind, prospective, randomized controlled trial with thirty-one stroke patients aged 35-80 who developed upper extremity spasticity. The study group (n = 16) received botulinum toxin-A (BT-A) injections in addition to conventional rehabilitation and stretching exercises, while the control group (n = 15) received placebo injections. Evaluations were conducted before treatment, in the second week, and three months after treatment. The study evaluated pain relief through the Visual Analog Scale (VAS), assessed spasticity with the Modified Ashworth Scale (MAS), and measured functionality using the Fugl Meyer Assessment Scale (FMAS) and the Box Block Test (BBT). Results: The mean age of patients was 56.03 +/- 11.81. The median time after stroke was 24 months. The BT-A group demonstrated significantly lower VAS and MAS scores compared to controls at both 2 weeks and 3 months after treatment. Additionally, the BT-A group showed significantly higher changes in arm, wrist, and total FMAS scores compared to the control group. However, no significant difference was found in terms of hand, coordination, and speed FMAS score changes. Conclusions: The results of our study demonstrated that BT-A injection with ultrasonography guidance is an effective method for alleviating pain caused by passive shoulder movement, significantly reducing spasticity, and markedly improving motor functions. (c) 2024 Sociedad Espanola de Rehabilitacio<acute accent>n y Medicina F & imath;<acute accent>sica. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:10
相关论文
共 27 条
  • [1] Incidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review
    Allison, Rhoda
    Shenton, Laura
    Bamforth, Kathryn
    Kilbride, Cherry
    Richards, David
    [J]. PHYSIOTHERAPY RESEARCH INTERNATIONAL, 2016, 21 (04) : 210 - 227
  • [2] A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke
    Bakheit, AMO
    Pittock, S
    Moore, AP
    Wurker, M
    Otto, S
    Erbguth, F
    Coxon, L
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 559 - 565
  • [3] Botulinum Toxin to Treat Upper-Limb Spasticity in Hemiparetic Patients: Analysis of Function and Kinematics of Reaching Movements
    Bensmail, Djamel
    Robertson, Johanna V. G.
    Fermanian, Christophe
    Roby-Brami, Agnes
    [J]. NEUROREHABILITATION AND NEURAL REPAIR, 2010, 24 (03) : 273 - 281
  • [4] Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial
    Bhakta, BB
    Cozens, JA
    Chamberlain, MA
    Bamford, JM
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (02) : 217 - 221
  • [5] EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
    Biering-Sorensen, Bo
    Stevenson, Valerie L.
    Bensmail, Djamel
    Grabljevec, Klemen
    Moreno, Mercedes Martinez
    Pucks-Faes, Elke
    Wissel, Joerg
    Zampolini, Mauro
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2022, 54
  • [6] Effectiveness of physical therapy interventions on post-stroke spasticity: An umbrella review
    Brusola, Gregory
    Garcia, Erica
    Albosta, Meagan
    Daly, Audrey
    Kafes, Konstandinos
    Furtado, Michael
    [J]. NEUROREHABILITATION, 2023, 52 (03) : 349 - 363
  • [7] Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso, Eduardo
    Pedreira, Glicia
    Prazeres, Antonio
    Ribeiro, Nildo
    Melo, Ailton
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (3A) : 592 - 595
  • [8] Effect of Upper Limb Botulinum Toxin Injections on Impairment, Activity, Participation, and Quality of Life Among Stroke Patients
    Caty, Gilles D.
    Detrembleur, Christine
    Bleyenheuft, Corinne
    Deltombe, Thierry
    Lejeune, Thierry M.
    [J]. STROKE, 2009, 40 (07) : 2589 - 2591
  • [9] Colhado Orlando Carlos Gomes, 2009, Rev. Bras. Anestesiol., V59, P366
  • [10] Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle
    de Boer, K. S.
    Arwert, H. J.
    de Groot, J. H.
    Meskers, C. G. M.
    Mishre, A. D. Rambaran
    Arendzen, J. H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (05) : 581 - 583